Retractable Technologies, Inc. (NYSE:RVP - Get Free Report) CEO Thomas J. Shaw purchased 15,363 shares of Retractable Technologies stock in a transaction dated Wednesday, April 17th. The stock was bought at an average cost of $1.03 per share, with a total value of $15,823.89. Following the completion of the transaction, the chief executive officer now owns 14,352,831 shares in the company, valued at approximately $14,783,415.93. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link.
Retractable Technologies Trading Up 1.0 %
RVP opened at $1.05 on Friday. The firm has a market cap of $31.44 million, a price-to-earnings ratio of -4.38 and a beta of 2.11. The company has a current ratio of 8.28, a quick ratio of 6.41 and a debt-to-equity ratio of 0.01. Retractable Technologies, Inc. has a 12 month low of $0.95 and a 12 month high of $1.88. The stock has a fifty day moving average price of $1.20 and a 200-day moving average price of $1.16.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in RVP. Millennium Management LLC acquired a new position in Retractable Technologies during the 2nd quarter valued at about $880,000. Vanguard Group Inc. increased its position in Retractable Technologies by 12.6% during the 1st quarter. Vanguard Group Inc. now owns 1,092,079 shares of the company's stock valued at $5,188,000 after buying an additional 122,231 shares in the last quarter. AQR Capital Management LLC increased its position in Retractable Technologies by 512.2% during the 2nd quarter. AQR Capital Management LLC now owns 107,890 shares of the company's stock valued at $413,000 after buying an additional 90,267 shares in the last quarter. Renaissance Technologies LLC increased its position in Retractable Technologies by 248.3% during the 2nd quarter. Renaissance Technologies LLC now owns 121,900 shares of the company's stock valued at $467,000 after buying an additional 86,900 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its position in Retractable Technologies by 314.2% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 58,400 shares of the company's stock valued at $96,000 after buying an additional 44,300 shares in the last quarter. 7.58% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Trump’s last act as President
From Porter & Company | Ad
You’ve probably never heard of Executive Order #13972.
Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines.
For the full story, click here.
Separately, StockNews.com assumed coverage on Retractable Technologies in a research report on Wednesday. They issued a "hold" rating for the company.
Get Our Latest Analysis on RVP
About Retractable Technologies
(
Get Free Report)
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
